Cardiac Ischemia

77.9% of patients with ischaemic heart disease were prescribed a lipid-lowering agent, with uptake lower among frail patients at 70.1%. Only 58.0% of patients with ischaemic heart disease were taking a renin-angiotensin system agent, the lowest uptake among the assessed medicine classes. 87.1% of patients with ischaemic heart disease were taking an antiplatelet or anticoagulant agent. Regular physical activity reduces cardiovascular mortality, recurrent cardiac events, and hospitalisation, and can improve quality of life in people with ischaemic heart disease. Ischaemic heart disease affected 18.6% of the cohort, with 93% of those patients also having multimorbidity. The study defined STEMI using chest pain duration plus ST-segment elevation thresholds in contiguous ECG leads. In this cohort of 1863 STEMI patients, 1-year all-cause mortality was 13.6%, with 254 deaths recorded. About half of people with ischaemic heart disease in Germany are physically inactive, mirroring the broader German population. Only about 21% of people with ischaemic heart disease in Germany meet current WHO physical activity recommendations. A systematic review found statins did not appear to confer morta…